TEBENTAFUSP for Choroid melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where TEBENTAFUSP was used for Choroid melanoma.
Most Reported Side Effects for TEBENTAFUSP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 35 | 35.7% | 12 | 22 |
| Pyrexia | 19 | 19.4% | 7 | 13 |
| Malignant neoplasm progression | 18 | 18.4% | 4 | 7 |
| Disease progression | 11 | 11.2% | 11 | 1 |
| Pruritus | 10 | 10.2% | 4 | 3 |
| Rash | 9 | 9.2% | 2 | 6 |
| Chills | 8 | 8.2% | 4 | 4 |
| Hypotension | 8 | 8.2% | 5 | 7 |
| Death | 7 | 7.1% | 7 | 0 |
| Vomiting | 7 | 7.1% | 5 | 5 |
| Diarrhoea | 5 | 5.1% | 3 | 4 |
| Fatigue | 5 | 5.1% | 0 | 5 |
| Oxygen saturation decreased | 5 | 5.1% | 3 | 4 |
Other Indications for TEBENTAFUSP
Uveal melanoma (33)
Product used for unknown indication (21)
Metastatic ocular melanoma (15)
Malignant melanoma (13)
Other Drugs Used for Choroid melanoma
IPILIMUMAB (46)
NIVOLUMAB (42)
PEMBROLIZUMAB (20)
RANIBIZUMAB (14)
TEBENTAFUSP-TEBN (10)
BEVACIZUMAB (7)
FOTEMUSTINE (5)
SORAFENIB (5)